Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-04-26 Purchase |
2024-04-29 08:30 am |
ABEONA THERAPEUTICS INC. | ABEO | Charles Faith L. Director |
7,550 | $3.28 | $24,764 | 78,323 (Direct) |
View |
2023-09-27 Sale |
2023-09-29 4:30 pm |
ABEONA THERAPEUTICS INC. | ABEO | Charles Faith L. Director |
8,330 | $4.9128 | $40,924 | 70,773 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-04-16 Option Award |
2025-04-17 4:05 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Charles Faith L. Director |
115,194 | $0.8681 | 165,238 (Direct) |
View |
2025-03-30 Option Award |
2025-04-01 9:04 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Charles Faith L. Director |
46,629 | $0.89 | 50,044 (Direct) |
View |
2025-01-31 Option Award |
2025-02-03 8:37 pm |
N/A N/A |
ABEONA THERAPEUTICS INC. | ABEO | Charles Faith L. Director |
36,101 | $0 | 149,832 (Direct) |
View |
2024-12-18 Option Award |
2024-12-20 5:06 pm |
N/A 2034-12-18 |
CONDUIT PHARMACEUTICALS INC. | CDT | Charles Faith L. Director |
420,000 | $0.071 | 420,000 (Direct) |
View |
2024-11-18 Option Award |
2024-11-20 4:30 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Charles Faith L. Director |
75,000 | $0 | 341,594 (Direct) |
View |
2024-11-18 Option Award |
2024-11-20 4:30 pm |
N/A N/A |
CONDUIT PHARMACEUTICALS INC. | CDT | Charles Faith L. Director |
266,594 | $0.0919 | 341,594 (Direct) |
View |
2024-09-23 Option Award |
2024-09-25 4:53 pm |
N/A 2034-09-23 |
AVENUE THERAPEUTICS INC. | ATXI | Charles Faith L. Director |
30,000 | $0 | 30,000 (Direct) |
View |
2024-08-26 Option Award |
2024-08-27 7:08 pm |
N/A N/A |
ABEONA THERAPEUTICS INC. | ABEO | Charles Faith L. Director |
11,797 | $0 | 113,731 (Direct) |
View |
2024-07-08 Option Award |
2024-07-09 4:35 pm |
N/A N/A |
ABEONA THERAPEUTICS INC. | ABEO | Charles Faith L. Director |
23,611 | $0 | 101,934 (Direct) |
View |
2024-04-08 Option Award |
2024-04-10 9:50 pm |
N/A 2034-04-08 |
CNS Pharmaceuticals Inc. | CNSP | Charles Faith L. Director |
35,000 | $0 | 112,130 (Direct) |
View |
2023-12-01 Option Award |
2023-12-05 5:20 pm |
N/A 2033-11-30 |
CONDUIT PHARMACEUTICALS INC. | CDT | Charles Faith L. Director |
65,000 | $5.51 | 65,000 (Direct) |
View |
2023-09-21 Option Award(A) |
2023-10-12 6:00 pm |
N/A 2033-09-22 |
CNS Pharmaceuticals Inc. | CNSP | Charles Faith L. Director |
26,315 | $0 | 29,815 (Direct) |
View |
2023-09-21 Option Award |
2023-09-25 6:20 pm |
N/A 2033-09-22 |
CNS Pharmaceuticals Inc. | CNSP | Charles Faith L. Director |
45,974 | $0 | 74,914 (Direct) |
View |
2023-06-30 Option Award |
2023-07-05 4:10 pm |
N/A 2033-06-30 |
AVENUE THERAPEUTICS INC. | ATXI | Charles Faith L. Director |
100,000 | $0 | 100,000 (Direct) |
View |
2023-06-14 Option Award |
2023-06-16 4:05 pm |
N/A N/A |
ABEONA THERAPEUTICS INC. | ABEO | Charles Faith L. Director |
58,689 | $4.62 | 79,103 (Direct) |
View |
2022-12-30 Option Award |
2023-01-04 4:02 pm |
N/A 2022-12-30 |
CNS Pharmaceuticals Inc. | CNSP | Charles Faith L. Director |
3,500 | $0 | 3,500 (Direct) |
View |
2022-09-26 Option Award |
2022-09-28 4:41 pm |
N/A N/A |
ABEONA THERAPEUTICS INC. | ABEO | Charles Faith L. Director |
13,400 | $0 | 20,414 (Direct) |
View |
2021-05-25 Option Award |
2021-05-27 9:46 pm |
N/A 2031-05-25 |
ABEONA THERAPEUTICS INC. | ABEO | Charles Faith L. Director |
175,349 | $0 | 175,349 (Direct) |
View |